CONQUEZA

DEAD

Serial Number

87026072

Owner

Teva Pharmaceuticals USA, Inc.

Filing Date

May 5, 2016

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

CONQUEZA Trademark

Serial Number: 87026072

CONQUEZA is a trademark filed by Teva Pharmaceuticals USA, Inc. on May 5, 2016. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Trademark Classes

Class 5 - Pharmaceuticals

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Owner Contact Info

Teva Pharmaceuticals USA, Inc. (587 trademarks)

650 Cathill Road
Sellersville, PA 18960

Entity Type: 03

Trademark Details

Filing Date

May 5, 2016

Registration Date

Not Registered

Published for Opposition

February 28, 2017

Goods & Services

Contraceptive preparations; Hormone replacement therapy preparations; Pharmaceutical preparations for the treatment and prevention of urinary incontinence and overactive bladder; Pharmaceutical preparations for the treatment and prevention of iron deficiency and anemia; Pharmaceutical preparations for the treatment and prevention of osteoporosis; Pharmaceutical preparations for the treatment and prevention of endometriosis; Pharmaceutical preparations for the treatment and prevention of symptoms associated with uterine fibroids; Iron chelating pharmaceutical preparations; Fertility enhancing pharmaceutical preparations; Pharmaceuticals and medicines for the treatment and prevention of sexual dysfunction; Pharmaceuticals and medicines for the treatment and prevention of disorders of the sensory organs; Pharmaceuticals and medicines for the treatment and prevention of disorders of the central nervous system; Pharmaceuticals and medicines for the treatment and prevention of disorders of the urogenital organs; Pharmaceuticals and medicines for the treatment and prevention of disorders of the circulatory systems; Pharmaceuticals and medicines for the treatment of cardiovascular diseases and blood pressure; Pharmaceuticals preparations for the treatment and prevention of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceutical preparations that support, encourage or promote bone strength or bone health or which are used in the treatment of bone disorders or bone diseases; Antibiotics; all the foregoing pharmaceuticals for human use

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

Jun 8, 2020 MAB6

ABANDONMENT - NO USE STATEMENT FILED

Jun 8, 2020 ABN6

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Oct 26, 2019 EXRA

SOU EXTENSION 5 GRANTED

Oct 25, 2019 EX5G

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Oct 24, 2019 AITU

SOU EXTENSION 5 FILED

Oct 22, 2019 EXT5

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Oct 22, 2019 TCCA

SOU TEAS EXTENSION RECEIVED

Oct 22, 2019 EEXT

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Apr 20, 2019 EXRA

SOU EXTENSION 4 GRANTED

Apr 18, 2019 EX4G

SOU EXTENSION 4 FILED

Apr 18, 2019 EXT4

SOU TEAS EXTENSION RECEIVED

Apr 18, 2019 EEXT

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Oct 20, 2018 EXRA

SOU EXTENSION 3 GRANTED

Oct 18, 2018 EX3G

SOU EXTENSION 3 FILED

Oct 18, 2018 EXT3

SOU TEAS EXTENSION RECEIVED

Oct 18, 2018 EEXT

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Apr 20, 2018 EXRA

SOU EXTENSION 2 GRANTED

Apr 18, 2018 EX2G

SOU EXTENSION 2 FILED

Apr 18, 2018 EXT2

SOU TEAS EXTENSION RECEIVED

Apr 18, 2018 EEXT

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Apr 18, 2018 TCCA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Oct 20, 2017 EXRA

SOU EXTENSION 1 GRANTED

Oct 18, 2017 EX1G

SOU EXTENSION 1 FILED

Oct 18, 2017 EXT1

SOU TEAS EXTENSION RECEIVED

Oct 18, 2017 EEXT

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Apr 25, 2017 NOAM

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Feb 28, 2017 NPUB

PUBLISHED FOR OPPOSITION

Feb 28, 2017 PUBO

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Feb 8, 2017 NONP

APPROVED FOR PUB - PRINCIPAL REGISTER

Jan 20, 2017 CNSA

EXAMINER'S AMENDMENT ENTERED

Jan 20, 2017 XAEC

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

Jan 20, 2017 GNEN

EXAMINERS AMENDMENT E-MAILED

Jan 20, 2017 GNEA

EXAMINERS AMENDMENT -WRITTEN

Jan 20, 2017 CNEA

TEAS/EMAIL CORRESPONDENCE ENTERED

Jan 9, 2017 TEME

CORRESPONDENCE RECEIVED IN LAW OFFICE

Jan 9, 2017 CRFA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Jan 9, 2017 TROA

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Jul 23, 2016 GNRN

NON-FINAL ACTION E-MAILED

Jul 23, 2016 GNRT

NON-FINAL ACTION WRITTEN

Jul 23, 2016 CNRT

ASSIGNED TO EXAMINER

Jul 19, 2016 DOCK

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

May 10, 2016 NWOS

NEW APPLICATION ENTERED

May 9, 2016 NWAP

Related Trademarks

More from this Owner

TEVA TOTAL SUPPORT

More in Same Class

SPONTANEOUS REMISSION INVESTIGATION

LEANFIRE

JUXEVA

ZIM'S LIDO-FREEZE

INDUCED REMISSION THERAPEUTICS

JILITY